ALNYLAM PHARMACEUTICALS, INC. : Alnylam Presents Complete Results ... 4-traders ... 300,000 hospitalizations per year in the U.S. RSV infection in lung transplant patients represents an important unmet medical need. Lung transplant patients infected with RSV are at risk for both acute rejection and a bronchiolitis obliterans ... |
